In human clear cell renal carcinomas (ccRCC), the phosphoinositide 3-kinase (PI3K)/protein kinase B (AKT)/mammalian target of rapamycin (mTOR) cascade is frequently mutated and activated. This evidence concerns the gene AKT1 and nonpapillary renal cell carcinoma.